Anemia as an independent predictor of adverse cardiac outcomes in patients with atrial fibrillation

International Journal of Medical Sciences

Volumn 12, Issue 8, 2015, Pages 618-624

  Lee, Wen Hsien ^a,b,c   Hsu, Po Chao ^a,c   Chu, Chun Yuan ^a   Lee, Hung Hao ^a   Lee, Meng Kuang ^a,b   Lee, Chee Siong ^a,c   Yen, Hsueh Wei ^a,c   Lin, Tsung Hsien ^a,c   Voon, Wen Chol ^a,c   Lai, Wen Ter ^a,c   Sheu, Sheng Hsiung ^a,c   Su, Ho Ming ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anemia; Atrial fibrillation; Cardiac outcomes; Hemoglobin

Indexed keywords

HEMOGLOBIN; ANTICOAGULANT AGENT;

ADVERSE OUTCOME; AGED; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR PARAMETERS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIASTOLIC MITRAL ANNULUS VELOCITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICULAR MASS INDEX; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; TRANSMITRAL E WAVE VELOCITY; BLOOD; CHEMISTRY; COMPLICATION; DIASTOLE; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SYSTOLE; TREATMENT OUTCOME;

AGED; ANEMIA; ANTICOAGULANTS; ATRIAL FIBRILLATION; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SYSTOLE; TREATMENT OUTCOME;

EID: 84938497732     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.11924     Document Type: Article

References (51)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2011;285: 2370-2375.
2. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the american college of cardiology/american heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): Developed in collaboration with the european heart rhythm association and the heart rhythm society. Circulation 2006;114: e257-354.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The framingham study. Stroke 1991;22: 983-988.
4. McManus DD, Hsu G, Sung SH, et al. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc 2013;2: e005694.
5. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/ Paisley study. Am J Med 2002;113: 359-364.
6. Kim MH, Johnston SS, Chu BC, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the united states. Circ Cardiovasc Qual Outcomes 2011;4: 313-320.
7. McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, who vitamin and mineral nutrition information system, 1993-2005. Public Health Nutr 2009;12: 444-454.
8. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol 2002;40: 27-33.
9. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008;52: 818-827.
10. Weiner DE, Tighiouart H, Vlagopoulos PT, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 2005;16: 1803-1810.
11. Mehdi U, Toto RD. Anemia, diabetes, and chronic kidney disease. Diabetes Care 2009;32: 1320-1326.
12. Lawler PR, Filion KB, Dourian T, et al. Anemia and mortality in acute coronary syndromes: A systematic review and meta-analysis. Am Heart J 2013;165: 143-153 e145.
13. Takabayashi K, Unoki T, Ogawa H, et al. Clinical characteristics of atrial fibrillation patients with anemia: From the fushimi af registry. Eur Heart J 2013;34 (suppl 1): P389.
14. Sharma S, Gage BF, Deych E, et al. Anemia: An independent predictor of death and hospitalizations among elderly patients with atrial fibrillation. Am Heart J 2009;157: 1057-1063.
15. Hamdan A, Shapira Y, Bengal T, et al. Tissue doppler imaging in patients with advanced heart failure: Relation to functional class and prognosis. J Heart Lung Transplant 2006;25: 214-218.
16. Dokainish H, Abbey H, Gin K, et al. Usefulness of tissue doppler imaging in the diagnosis and prognosis of acute right ventricular infarction with inferior wall acute left ventricular infarction. Am J Cardiol 2005;95: 1039-1042.
17. Chen SC, Chang JM, Liu WC, et al. Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Nephrol Dial Transplant 2012;27: 1064-1070.
18. Chang JM, Chen SC, Huang JC, et al. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease. Am J Med Sci 2013;347: 183-189.
19. Ersboll M, Andersen MJ, Valeur N, et al. The prognostic value of left atrial peak reservoir strain in acute myocardial infarction is dependent on left ventricular longitudinal function and left atrial size. Circ Cardiovasc Imaging 2013;6: 26-33.
20. Motoki H, Borowski AG, Shrestha K, et al. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure. J Am Coll Cardiol 2012;60: 2074-2081.
21. Su HM, Lin TH, Hsu PC, et al. Association of interankle systolic blood pressure difference with peripheral vascular disease and left ventricular mass index. Am J Hypertens 2014;27: 32-37.
22. Su HM, Lin TH, Hsu PC, et al. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart 2013;99: 1588-1596.
23. Hsu PC, Lee WH, Chu CY, et al. The ratio of early mitral inflow velocity to global diastolic strain rate as a useful predictor of cardiac outcomes in patients with atrial fibrillation. J Am Soc Echocardiogr 2014;27:717-725.
24. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57: 450-458.
25. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr 2005;18: 1440-1463.
26. Govindan M, Kiotsekoglou A, Saha SK, et al. Validation of echocardiographic left atrial parameters in atrial fibrillation using the index beat of preceding cardiac cycles of equal duration. J Am Soc Echocardiogr 2011;24: 1141-1147.
27. Lee CS, Lin TH, Hsu PC, et al. Measuring left ventricular peak longitudinal systolic strain from a single beat in atrial fibrillation: Validation of the index beat method. J Am Soc Echocardiogr 2012;25: 945-952.
28. Kusunose K, Yamada H, Nishio S, et al. Index-beat assessment of left ventricular systolic and diastolic function during atrial fibrillation using myocardial strain and strain rate. J Am Soc Echocardiogr 2012;25: 953-959.
29. Sohn DW, Song JM, Zo JH, et al. Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr 1999;12: 927-931.
30. Wang CL, Lin KH, Luqman N, et al. Refinement on single-beat determination of left ventricular systolic function in patients with atrial fibrillation. J Am Soc Echocardiogr 2005;18: 913-918.
31. Govindan M, Kiotsekoglou A, Saha SK, et al. Validation of echocardiographic left atrial parameters in atrial fibrillation using the index beat of preceding cardiac cycles of equal duration. J Am Soc Echocardiogr 2011;24: 1141-1147.
32. World health organization. Hhaemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. 2011:1-6.
33. Brown DW, Giles WH, Croft JB. Hematocrit and the risk of coronary heart disease mortality. Am Heart J. 2001;142:657-663.
34. Kotecha D, Ngo K, Walters JA, et al. Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials. Am Heart J. 2011;161:822-831 e822.
35. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-1744.
36. Bolger AP, Bartlett FR, Penston HS, et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol. 2006;48:1225-1227.
37. Palazzuoli A, Silverberg D, Iovine F, et al. Erythropoietin improves anemia exercise tolerance and renal function and reduces b-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J. 2006;152:1096 e1099-1015.
38. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-1236.
39. Nikolsky E, Mehran R, Sadeghi HM, et al. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: Analysis from the cadillac (controlled abciximab and device investigation to lower late angioplasty complications) trial. JACC Cardiovasc Interv. 2009;2:624-632.
40. Jolicoeur EM, O'Neill WW, Hellkamp A, et al. Transfusion and mortality in patients with st-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J. 2009;30:2575-2583.
41. Puurunen M, Kiviniemi T, Nammas W, et al. Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: Insights from the afcas registry. BMJ Open. 2014;4:e004700.
42. Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the solvd trials. Studies of left ventricular dysfunction. J Am Coll Cardiol. 1998;32:695-703.
43. McMurray JJ, Ezekowitz JA, Lewis BS, et al. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: Insights from the aristotle trial. Circ Heart Fail. 2013;6:451-460.
44. Kosiuk J, Van Belle Y, Bode K, et al. Left ventricular diastolic dysfunction in atrial fibrillation: Predictors and relation with symptom severity. J Cardiovasc Electrophysiol. 2012;23:1073-1077.
45. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317-327.
46. Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006;47:1997-2004.
47. Badheka AO, Shah N, Grover PM, et al. Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy. Am J Cardiol. 2014;113:1159-1165.
48. Metivier F, Marchais SJ, Guerin AP, et al. Pathophysiology of anaemia: Focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15 Suppl 3:14-18.
49. Anand IS, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of oedema in chronic severe anaemia: Studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. British heart journal. 1993;70:357-362.
50. Tang YD, Katz SD. Anemia in chronic heart failure: Prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006;113:2454-2461.
51. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110:149-154.